echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > GSK plans to hire doctors to promote its drugs

    GSK plans to hire doctors to promote its drugs

    • Last Update: 2014-03-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: DXY UK pharmaceutical giant GlaxoSmithKline said on March 20, 2014 that it plans to hire doctors to train doctors instead of paying opinion leaders to promote its products in meetings and other activities GlaxoSmithKline announced in December that it was changing its marketing strategy to eliminate undue influence on doctors The company said it would stop paying doctors to speak or attend meetings on its behalf from 2016 In an interview with Bloomberg, Deirdre Connelly, head of GlaxoSmithKline's U.S pharmaceutical business, said hiring doctors and scientists as representatives of the company to promote drugs would bring greater transparency "We will continue to promote important information on drug benefits and risks, but we will not just do this by hiring external speakers," she said We want to make sure that people think we're doing the right thing " A spokesman for GlaxoSmithKline said: "it is important that we continue to provide doctors with information about the benefits and risks of our drugs, but we want to do these things in a modern way to eliminate any conflict of interest Some of the changes we are making to our sales and marketing strategies include strengthening our scientific and medical capabilities This doesn't mean that we just bring opinion leaders inside the company, but that there are more doctors and scientists inside the company to approach their colleagues in a transparent way " Since 2009, GlaxoSmithKline has reduced its sales force by 30% and expanded its internal education staff, such as those targeting pharmacies, Connelly said The company has faced a number of scandals in recent years, and some commentators see the change as a way to rebuild its reputation GlaxoSmithKline's Chinese executives, who are under investigation, have been accused of bribing doctors to improve drug sales, and last year the company was fined a record $3 billion in the US for unethical and illegal marketing of drugs.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.